Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors

NCT00024141 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: fluorouracil
DRUG: irinotecan hydrochloride

Sponsor

Roswell Park Cancer Institute